Hosted on MSN18m
USPTO grants patent to Vistagen’s neuropathic pain treatment
The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for neuropathic pain treatment. This patent is set to remain in effect until at ...
Trump Return-to-Office Order Faces Big Exemption at Patent Office
The US Patent and Trademark Office told employees Friday the agency will fully comply with President Donald Trump’s return-to ...